Rainbow Childrens Medicare Ltd's Q4FY25 Quarterly Results

Result Summary

• Rainbow Childrens Medicare Ltd reported a 14.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 8.6%.
• Its expenses for the quarter were down by 10.2% QoQ and up 11.3% YoY.
• The net profit decreased 25.9% QoQ and decreased 5.2% YoY.
• The earnings per share (EPS) of Rainbow Childrens Medicare Ltd stood at 5 during Q4FY25.

Financial Statments for Q4FY25

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Rainbow Childrens Medicare Ltd is a renowned provider of pediatric healthcare services. The company primarily focuses on delivering specialized services in child health, including neonatal and pediatric intensive care, pediatric multi-specialty services, and pediatric surgeries. Rainbow Childrens Medicare Ltd operates within the healthcare industry, which is characterized by a growing demand for specialized medical services. However, specific recent developments or strategic initiatives by the company are not available in the provided data. The company's commitment to offering quality healthcare to children positions it as a key player in the pediatric healthcare sector.

Revenue

In Q4FY25, Rainbow Childrens Medicare Ltd reported a total income of ₹353.88 crores. This represents a decline of 14.0% compared to the previous quarter, Q3FY25, where total income was ₹411.36 crores. Despite the quarterly decline, there was an increase of 8.6% in total income on a year-over-year basis from Q4FY24, where total income was ₹325.86 crores. This year-over-year increase highlights an improvement in revenue generation compared to the previous year. The company's revenue performance is a crucial indicator of its ability to generate income from its healthcare services.

Profitability

The company's profitability in Q4FY25 experienced a decline compared to the previous quarter. The Profit Before Tax (PBT) was ₹69.17 crores, down 26.7% from ₹94.33 crores in Q3FY25. On a year-over-year basis, PBT showed a slight decrease of 1.3% from ₹70.10 crores in Q4FY24. The Profit After Tax (PAT) for Q4FY25 was ₹51.06 crores, a reduction of 25.9% quarter-over-quarter from ₹68.94 crores in Q3FY25, and a 5.2% decrease year-over-year from ₹53.87 crores in Q4FY24. Earnings per Share (EPS) also saw a decrease, being ₹5.00 in Q4FY25, compared to ₹6.80 in Q3FY25 and ₹5.30 in Q4FY24. These figures provide insight into the company's profitability during the reported period.

Operating Metrics

Operating expenses for Rainbow Childrens Medicare Ltd in Q4FY25 amounted to ₹284.71 crores, which represents a 10.2% decrease from ₹317.02 crores in Q3FY25. Year-over-year, total expenses increased by 11.3% from ₹255.76 crores in Q4FY24. The company's tax expense also declined by 28.7% quarter-over-quarter from ₹25.39 crores in Q3FY25 to ₹18.11 crores in Q4FY25, while showing an 11.5% increase from ₹16.24 crores in Q4FY24. These operating metrics illustrate the company's cost management and tax liabilities across the quarters.